factive
Factive (Gemifloxacin Mesylate) is a medication used to treat Bronchitis, Pneumococcal Pneumonia, Urinary Tract Infections, Gram-Negative Bacterial Infections.
Gemifloxacin Mesylate · by Lg Chem Ltd
Key facts
- Active ingredient
- Gemifloxacin Mesylate
- Form
- Tablet
- Strength
- Gemifloxacin Mesylate EQ 320MG Base **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- bronchitis, pneumococcal pneumonia, urinary tract infections
- Manufacturer
- Lg Chem Ltd
- FDA application
- NDA021158
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- bronchitis
- pneumococcal pneumonia
- urinary tract infections
- gram-negative bacterial infections
- community-acquired infections
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Factive treat?
- Factive (Gemifloxacin Mesylate) may be used to treat bronchitis, pneumococcal pneumonia, urinary tract infections, gram-negative bacterial infections, community-acquired infections, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Factive?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Factive. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Factive?
- Factive is marketed by Lg Chem Ltd. You can see Lg Chem Ltd's full profile, rating, and other products on pharmaranks.
- Is Factive a brand-name or generic drug?
- Factive is a brand-name product with the active ingredient Gemifloxacin Mesylate.
- Is Factive available over the counter?
- No. Factive is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Factive come in?
- Factive is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Factive FDA-registered?
- Factive is on record with the U.S. FDA under application number NDA021158. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about GEMIFLOXACIN MESYLATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 9 reports naming GEMIFLOXACIN MESYLATE — the active ingredient in Factive, and the FDA flagged 78% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dyspnoea2 reports
- oedema2 reports
- anaphylactic reaction1 reports
- balance disorder1 reports
- blood creatinine increased1 reports
- blood pressure decreased1 reports
- dizziness1 reports
- foreign body aspiration1 reports
Read these as a signal, not a rate. A report does not mean GEMIFLOXACIN MESYLATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
atrovent hfa
Ipratropium Bromide
blujepa
Gepotidacin Mesylate
cayston
Aztreonam
cefixime
Cefixime
chg scrub
Chlorhexidine Gluconate
cida-stat
Chlorhexidine Gluconate
Compare Factive head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.